GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoNex Inc (ROCO:4168) » Definitions » Other Gross PPE

GlycoNex (ROCO:4168) Other Gross PPE : NT$826.28 Mil (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is GlycoNex Other Gross PPE?

GlycoNex's Other Gross PPE for the quarter that ended in Sep. 2024 was NT$826.28 Mil.

GlycoNex's quarterly Other Gross PPE increased from Mar. 2024 (NT$830.99 Mil) to Jun. 2024 (NT$834.34 Mil) but then declined from Jun. 2024 (NT$834.34 Mil) to Sep. 2024 (NT$826.28 Mil).

GlycoNex's annual Other Gross PPE declined from Dec. 2021 (NT$1,021.94 Mil) to Dec. 2022 (NT$989.92 Mil) and declined from Dec. 2022 (NT$989.92 Mil) to Dec. 2023 (NT$813.65 Mil).


GlycoNex Other Gross PPE Historical Data

The historical data trend for GlycoNex's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoNex Other Gross PPE Chart

GlycoNex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,090.99 1,054.65 1,021.94 989.92 813.65

GlycoNex Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 811.15 813.65 830.99 834.34 826.28

GlycoNex Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


GlycoNex Business Description

Traded in Other Exchanges
N/A
Address
Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221
GlycoNex Inc is a Taiwan based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The Company also provides antibody research services to its academic and industrial clients. The other services provided by the firm include functional evaluation and antibody engineering. The company has two segments which are antibody new drugs and exclusive investment. It earns the majority of its revenue from the antibody new drugs segment.

GlycoNex Headlines

No Headlines